title: Pulmonary uptake of sestamibi on early post-stress images: angiographic relationships, incidence and kinetics.
abstract: Early post-stress imaging with 99Tcm-sestamibi has the potential to reveal ancillary markers of severe coronary artery disease. Lung/myocardial ratios of sestamibi were assessed after pharmacologic, exercise or combined stress, and these were compared with historical controls who were stressed similarly, but imaged with 201Tl. Forty initial patients had planar imaging and correlating angiograms; pulmonary uptake for sestamibi related to severe coronary artery stenoses when measured on immediate images, started at 4 min post-stress (P = 0.04), but had a poor relationship to angiographic findings when measured on delayed clinical images. Of 180 subsequent studies, increased pulmonary uptake of sestamibi was seen more frequently (incidence = 34%) in those with abnormal tomograms compared to those with normal tomograms (incidence = 13%, P < 0.01), but appeared less frequently than on abnormal 201Tl studies (incidence = 60%). With sequential imaging for 5 min after injection, pulmonary uptake showed a greater fall with time on sestamibi studies than on matched 201Tl studies. No consistent differences were seen among the stress modalities. As an ancillary sign of haemodynamically severe disease, increased pulmonary uptake can be seen after various stress modalities, but may be more difficult to apply with sestamibi than with thallium imaging.
authors.affiliation: Department of Diagnostic Radiology/Nuclear Medicine, University of Western Ontario, London, Canada.
authors.forename: G A
authors.initials: GA
authors.lastname: Hurwitz
authors.forename: S P
authors.initials: SP
authors.lastname: Fox
authors.forename: A A
authors.initials: AA
authors.lastname: Driedger
authors.forename: C
authors.initials: C
authors.lastname: Willems
authors.forename: J E
authors.initials: JE
authors.lastname: Powe
mesh_terms: D017023:Coronary Angiography; D003327:Coronary Disease / Q000000981:diagnostic imaging* / Q000453:epidemiology; D005080:Exercise Test; D006801:Humans; D008168:Lung / Q000378:metabolism*; D009864:Ontario / Q000453:epidemiology; D011877:Radionuclide Imaging; D012189:Retrospective Studies; D017256:Technetium Tc 99m Sestamibi / Q000493:pharmacokinetics*; D013997:Time Factors
chemical_list: D017256:Technetium Tc 99m Sestamibi